Ethical guidelines for conducting clinical trials have historically been based on a perceived therapeutic obligation to treat and benefit the patient-participants. The origins of this ethical framework can be traced to the Hippocratic oath originally written to guide doctors in caring for their patients, where the overriding moral obligation of doctors is strictly to do what is best for the individual patient, irrespective of other social considerations. In contrast, although medicine focuses on the health of the person, public health is concerned with the health of the entire population, and thus, public health ethics is founded on the societal responsibility to protect and promote the health of the population as a whole. From a public health perspective, research ethics should be guided by giving due consideration to the risks and benefits to society in addition to the individual research participants. On the basis of a duty to protect the population as a whole, a fiduciary obligation to realise the social value of the research and the moral responsibility to distribute the benefits and burdens of research fairly across society, how a public health perspective on research ethics results in fundamental re-assessments of the proper course of action for two salient topical issues in research ethics is shown: stopping trials early for reasons of efficacy and the conduct of research on less expensive yet less effective interventions.
- KKI, Kennedy–Kreiger Institute
- RCT, randomised controlled trial
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Competing interests: None.
Read the full text or download the PDF:
Other content recommended for you
- Limits to research risks
- Health incentive research and social justice: does the risk of long term harms to systematically disadvantaged groups bear consideration?
- The ethics of attaching research conditions to access to new health technologies
- Informed consent in cluster randomised trials: new and common ethical challenges
- Stopping trials early for commercial reasons: the risk–benefit relationship as a moral compass
- Challenges to biobanking in LMICs during COVID-19: time to reconceptualise research ethics guidance for pandemics and public health emergencies?
- What makes clinical labour different? The case of human guinea pigging
- Practical metrics for establishing the health benefits of research to support research prioritisation
- Right of the living dead? Consent to experimental surgery in the event of cortical death
- Individual and public interests in clinical research during epidemics: a reply to Calain